Skip to main content
main-content

26.02.2019 | Original Research Article | Ausgabe 3/2019

Documenta Ophthalmologica 3/2019

Corosolic acid: antiangiogenic activity and safety of intravitreal injection in rats eyes

Zeitschrift:
Documenta Ophthalmologica > Ausgabe 3/2019
Autoren:
Cibele Rodrigues Toledo, Vinícius Viana Pereira, Lays Fernanda Nunes Dourado, Mayara Rodrigues Brandão Paiva, Armando Silva-Cunha
Wichtige Hinweise

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Abstract

Purpose

Investigate the potential application of corosolic acid (CA) in the treatment of diseases causing retinal neovascularization.

Methods

CA cytotoxicity effect was evaluated in ARPE-19 cells by sulforhodamine B colorimetric method, and antiangiogenic activity was studied using chorioallantoic membrane (CAM) assay. An amount of 0.01 mL of CA formulations at 5, 10 and 25 µM was injected in the right eyes of Wistar rats, and the contralateral eyes received the vehicle to verify the safety of ophthalmic use. Electroretinography (ERG) was performed before, 7 and 15 days after CA administration. Animals were killed on the 15th day, and the histological analysis of retina was carried out under light microscopy.

Results

CA did not present cytotoxicity at concentrations below 35.5 μM after 48 h of treatment. The antiangiogenic activity was confirmed by CAM assay, since CA (range from 5 to 25 µM) induced a significant reduction in vascularity without any signs of toxicity. ERG recordings and histological evaluation did not show any signs of retinal toxicity.

Conclusions

CA was effective in reducing vascularity in a CAM model and was found to be safe for potential ophthalmic use.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

★ PREMIUM-INHALT
e.Med Interdisziplinär

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de. Zusätzlich können Sie eine Zeitschrift Ihrer Wahl in gedruckter Form beziehen – ohne Aufpreis.

Jetzt bestellen und im ersten Jahr 100€ sparen!Jetzt e.Med zum Sonderpreis bestellen!

Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 3/2019

Documenta Ophthalmologica 3/2019 Zur Ausgabe


 

Neu im Fachgebiet Augenheilkunde

Bildnachweise